1186663-31-9 Usage
General Description
2-Amino-4-(chloromethyl)pyridine hydrochloride is a yellow powder chemical compound that is commonly used in organic synthesis as a building block for pharmaceuticals, agrochemicals, and other fine chemicals. It is known for its reactivity and versatility in creating complex molecular structures. The hydrochloride salt form of this compound enhances its solubility in water and makes it easier to handle in a laboratory setting. 2-Amino-4-(chloromethyl)pyridine hydrochloride is typically used as a key intermediate in the synthesis of various heterocyclic compounds and is a useful tool in medicinal and process chemistry research. It has potential applications in the development of new drugs and compounds for a wide range of industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1186663-31-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,8,6,6,6 and 3 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1186663-31:
(9*1)+(8*1)+(7*8)+(6*6)+(5*6)+(4*6)+(3*3)+(2*3)+(1*1)=179
179 % 10 = 9
So 1186663-31-9 is a valid CAS Registry Number.
1186663-31-9Relevant articles and documents
NOVEL COMPOUND, ORGANIC CATION TRANSPORTER 3 DETECTION AGENT, AND ORGANIC CATION TRANSPORTER 3 ACTIVITY INHIBITOR
-
Paragraph 0515-0516; 0521, (2016/08/17)
[Problem] The present invention addresses the problem of providing a novel compound. The present invention also addresses the problem of providing an OCT3 detection agent or an OCT3 activity inhibitor, which comprises the novel compound. [Solution] A compound represented by formula (A), a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof. ????????R1-R2-R3-R4?????(A)
2-AMINOTHIOPHENECARBOXAMIDES USEFUL AS CANCER CHEMOTHERAPEUTIC AGENTS
-
Page/Page column 32, (2010/10/20)
This invention relates to novel 2-aminothiophenecarboxamide compounds, pharmaceutical compositions containing such compounds, and the use of those compounds or compositions as cancer chemotherapeutic agents.
